1don MSN
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the ...
Morning Overview on MSN
Novartis, Amgen, Lilly target Lp(a) in bid for next heart drugs
Statins cannot touch it. Neither can diet or exercise. Lipoprotein(a), a cholesterol-like particle hardwired into a person’s ...
New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major ...
Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more ...
April 28 (Reuters) - Pfizer said on Tuesday it has settled patent disputes with three generic drugmakers over its blockbuster ...
Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ...
If you’re looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) receptor ...
In their analysis, the authors evaluated the effects of commonly used cardiovascular medications in patients with multiple myeloma. These widely prescribed drugs, used to manage high blood pressure, ...
Everyday Health on MSN
12 Drugs to Avoid if You Have Obstructive Hypertrophic Cardiomyopathy
Learn which common medications you need to avoid when you have oHCM, including some for blood pressure and erectile ...
ScienceAlert on MSN
Common Gout Medications Linked to Lower Risk of Heart Attack And Stroke
Gout causes severe soreness in body joints. (Sebastian Kaulitzki/Science Photo Library/Getty Images) Medications commonly ...
GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, ...
Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of patients with multiple myeloma. SHARJAH, EMIRATE OF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results